PExA AB Logo

PExA AB

Offers non-invasive lung liquid biopsy tech for respiratory disease research.

PEXA B | SPGR

Overview

Corporate Details

ISIN(s):
SE0007412366 (+1 more)
LEI:
5493000H96U6ILH5V269
Country:
Sweden
Address:
Arvid Wallgrens Backe 20, 413 46 Göteborg
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

PExA AB is a medical technology company that develops and commercializes a unique, non-invasive technology for biomarker discovery in respiratory medicine. The company's patented PExA system facilitates the collection of Respiratory Tract Lining Fluid (RTLF) from the most distal airways by sampling particles from exhaled air. This method provides a 'liquid biopsy for the lungs,' enabling quantitative and reproducible measurements for research into early diagnostics and targeted treatments for respiratory diseases. PExA offers research instruments, such as the PExA 2.1, along with associated consumables and analytical services to academic research centers, healthcare organizations, and pharmaceutical companies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all PExA AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PExA AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PExA AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-10 Erik Svante Höjer Other Buy 100,000 19,000.00 SEK
2024-11-29 Bengt Tomas Jan Gustafsson Other Buy 100,000 31,600.00 SEK

Peer Companies

Nuwellis, Inc. Logo
Develops an ultrafiltration system to remove excess fluid from diuretic-resistant patients.
United States of America
NUWE
OMNICELL, INC. Logo
Automating medication management for healthcare providers with robotics and intelligent software.
United States of America
OMCL
ONCOSEM ONKOLOJİK SİSTEMLER SANAYİ VE TİCARET A.Ş. Logo
Manufactures automated systems & devices for safe, efficient oncology chemotherapy treatment.
Türkiye
ONCSM
Develops photodisinfection therapies to combat antimicrobial resistance and prevent infections.
Canada
OBI
Onward Medical N.V. Logo
Develops spinal stimulation therapies to restore movement for people with spinal cord injury.
Netherlands
ONWD
Orchestra BioMed Holdings, Inc. Logo
Develops bioelectronic & drug/device therapies for hypertension and artery disease.
United States of America
OBIO
Organogenesis Holdings Inc. Logo
Develops regenerative biomaterials for wound care, surgical, and sports medicine markets.
United States of America
ORGO
Orthofix Medical Inc. Logo
Delivering musculoskeletal solutions like spinal hardware & biologics to global health providers.
United States of America
OFIX
ORTHOPEDIATRICS CORP Logo
Designs, develops, and markets orthopedic implants and instruments exclusively for children.
United States of America
KIDS
OSANG HEALTHCARE CO.,LTD. Logo
Develops and manufactures IVD medical devices and biosensors for diabetes management and health monitoring.
South Korea
036220

Talk to a Data Expert

Have a question? We'll get back to you promptly.